NH Amundi Asset Management, HANARO K-Meditech ETF Listed

Investment in Domestic Medical Tech and Innovative Medical Device Companies

NH-Amundi Asset Management listed the 'HANARO K-Meditech' Exchange Traded Fund (ETF) on the 21st.

Meditech refers to advanced technologies applicable across the entire healthcare spectrum, including disease prevention, diagnosis, and treatment. It is applied in various fields such as medical devices, solutions, and medical materials. With the advancement of related technologies like aging population, information technology (IT), life sciences, and robotics, interest in healthcare and beauty has increased, making it a promising industry with sustainable growth potential.

According to NH-Amundi Asset Management on the day, the HANARO K-Meditech ETF invests in 20 domestic Meditech and innovative medical-related stocks based on the iSelect K-Meditech Index. This index consists of stocks representing the domestic Meditech industry, including AI medical devices and solutions, dental, cosmetic medical devices, diagnostic devices, and medical materials. Top holdings include Vuno, known for medical data analysis and disease prediction; Lunit, an AI medical imaging interpretation company; JLK, a stroke medical AI solution company; Classys, a cosmetic medical device specialist; and Curexo, a surgical robot specialist.

Recently, the medical industry is experiencing a turning point of innovation with the remarkable development of foundational technologies such as AI, robotics, and the Internet of Things (IoT). Meditech is emerging across all medical fields, including improved precision in medical image interpretation, disease prediction and prevention through personal medical data analysis, and precision robots for surgical assistance," the company explained. According to global research firm Statista, medical AI is expected to maintain an average annual growth rate of about 37% from 2021 to 2030, forming a market worth approximately $190 billion by 2030.

The domestic medical industry is also expected to be fostered as a representative export industry with government support. In April this year, the government announced various policy supports through the Medical Device Industry Promotion Strategy, including increasing research and development investment to 10 trillion won by 2027, supporting domestic and international clinical trials and overseas expansion, improving regulations on innovative technologies, and creating an industrial ecosystem.

Kim Hyun-bin, Head of ETF Investment at NH-Amundi Asset Management, said, "Meditech, a convergence of advanced technologies such as medical care, AI, and robotics, is bringing innovation across the entire medical field and will accelerate the growth of related industries."